Showing 1 - 20 results of 24 for search 'Aoki, Y', query time: 0.07s
Refine Results
-
1
Emerging oligonucleotide therapeutics for rare neuromuscular diseases by Aoki, Y, Wood, MJA
Published 2021Journal article -
2
New Approach for Antisense Oligonucleotide-Mediated Exon Skipping in Duchenne Muscular Dystrophy. by Aoki, Y, Nagata, T, Takeda, S
Published 2012Journal article -
3
Challenges for antisense oligonucleotide-based therapeutics, in particular for exon 51-skipping in Duchenne muscular dystrophy by Aoki, Y, Nagata, T, Shimizu, Y, Takeda, S
Published 2011Journal article -
4
Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors by Miyatake S, Shimizu-Motohashi Y, Takeda S, Aoki Y
Published 2016-08-01
Article -
5
-
6
-
7
Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases by Tsoumpra, MK, Fukumoto, S, Matsumoto, T, Takeda, S, Wood, MJA, Aoki, Y
Published 2019Journal article -
8
Multidisciplinary Management of Costello Syndrome: Current Perspectives by Leoni C, Viscogliosi G, Tartaglia M, Aoki Y, Zampino G
Published 2022-06-01
Article -
9
In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. by Aoki, Y, Nakamura, A, Yokota, T, Saito, T, Okazawa, H, Nagata, T, Takeda, S
Published 2010Journal article -
10
Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient by Saito, T, Nakamura, A, Aoki, Y, Yokota, T, Okada, T, Osawa, M, Takeda, S
Published 2010Journal article -
11
Problems in Social Medicine Related to Alcohol and Deaths: Autopsy Cases in the Southern Part of Osaka City by Tani N, Ikeda T, Hirokawa T, Aoki Y, Shida A, Ikeda K, Morioka F, Ishikawa T
Published 2021-10-01
Article -
12
Development of LNA gapmer oligonucleotide-based therapy for ALS/FTD caused by the C9orf72 repeat expansion by Sathyaprakash, C, Manzano, R, Varela, MA, Hashimoto, Y, Wood, MJA, Talbot, K, Aoki, Y
Published 2020Journal article -
13
-
14
Synthesis of 2'-O-[2-(N-methylcarbamoyl)ethyl]ribonucleosides using oxa-Michael reaction and chemical and biological properties of oligonucleotide derivatives incorporating these m... by Yamada, T, Okaniwa, N, Saneyoshi, H, Ohkubo, A, Seio, K, Nagata, T, Aoki, Y, Takeda, S, Sekine, M
Published 2011Journal article -
15
-
16
Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery. by Aoki, Y, Yokota, T, Nagata, T, Nakamura, A, Tanihata, J, Saito, T, Duguez, S, Nagaraju, K, Hoffman, E, Partridge, T, Takeda, S
Published 2012Journal article -
17
-
18
Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. by Roberts, T, Godfrey, C, McClorey, G, Vader, P, Briggs, D, Gardiner, C, Aoki, Y, Sargent, I, Morgan, J, Wood, M
Published 2013Journal article -
19
Novel EGFP reporter cell and mouse models for sensitive imaging and quantification of exon skipping by Hara, Y, Mizobe, Y, Inoue, YU, Hashimoto, Y, Motohashi, N, Masaki, Y, Seio, K, Takeda, S, Nagata, T, Wood, MJA, Inoue, T, Aoki, Y
Published 2020Journal article -
20
Fine tuning of phosphorothioate inclusion in 2'-O-methyl oligonucleotides contributes to specific cell targeting for splice-switching modulation by Aoki, Y, Rocha, CSJ, Lehto, T, Miyatake, S, Johansson, H, Hashimoto, Y, Nordin, JZ, Mager, I, Aoki, M, Graham, M, Sathyaprakash, C, Roberts, TC, Wood, MJA, Behlke, MA, Andaloussi, SE
Published 2021Journal article